Johnson & Johnson maintains sales in Q2 21-Jul-2010

Johnson & Johnson has announced a slight increase in sales for its second quarter with sales up 0.6% reaching $15.3bn. Operational results grew 0.1%, while international sales increased 4.1%, however domestic sales suffered a 2.8% loss.

Net earnings per share were $3.4bn which included an after tax gain of $67m due to the impact of litigation matters.

The company’s Neutrogena brand was a strong contributor to the positive operational results, as was sales of Johnson’s baby care products and adult skin products.

“Our second quarter results include strong growth in a number of our recently launched products which contributed to solid earnings,” said William C Weldon, chairman and ceo. “We continue to make significant investments in acquisitions, strategic partnerships and in advancing our pipeline, positioning us well for future growth.”